We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Given Imaging Strengthens Position in Gastroesophageal Diagnostic Market

By LabMedica International staff writers
Posted on 13 Apr 2010
Given Imaging Ltd. More...
(Yoqne'am, Israel) completed its acquisition of the privately held diagnostics company, Sierra Scientific Instruments (Los Angeles, CA, USA), for US$35 million in cash. As a result of the purchase, Sierra Scientific has become a wholly owned subsidiary of Given Imaging.

Products developed by Given Imaging use wireless technology and advanced software to enable gastroenterologists visualize diseases of the esophagus, small bowel, and colon. The PillCam capsules are miniature video cameras that patients ingest. Capsule endoscopy provides physicians with natural images of the small intestine via PillCam SB, the esophagus through PillCam ESO, and the colon with PillCam COLON.

Other capsule products developed by Given Imaging include Agile patency capsule, to verify intestinal patency, and Bravo, a wireless, catheter-free, 48-hour pH test, which is used to assess gastroesophageal reflux disease (GERD).

Given Imaging has operating subsidiaries in the United States, Germany, France, Japan, Australia, and Singapore.

Sierra Scientific's products diagnose a range of gastrointestinal disorders, including gastroesophageal reflux disease. The company developed high-resolution manometry through its ManoScan family of products. It also offers a line of reflux monitoring solutions (AccuTrac and Digitrapper), as well as the Polygraf ID stationary gastrointestinal function testing platform.

Related Links:

Given Imaging Ltd.
Sierra Scientific Instruments




New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Rapid Sepsis Test
SeptiCyte RAPID
New
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.